Ziresovir
Modify Date: 2024-01-07 20:34:54
Ziresovir structure
|
Common Name | Ziresovir | ||
|---|---|---|---|---|
| CAS Number | 1422500-60-4 | Molecular Weight | 439.531 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 745.4±70.0 °C at 760 mmHg | |
| Molecular Formula | C22H25N5O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 404.6±35.7 °C | |
Use of ZiresovirZiresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species[1]. |
| Name | N-[(3-Amino-3-oxetanyl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methyl-4-quinazolinamine |
|---|---|
| Synonym | More Synonyms |
| Description | Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 3 nM (RSV F)[1] |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 745.4±70.0 °C at 760 mmHg |
| Molecular Formula | C22H25N5O3S |
| Molecular Weight | 439.531 |
| Flash Point | 404.6±35.7 °C |
| Exact Mass | 439.167816 |
| LogP | 0.26 |
| Vapour Pressure | 0.0±2.5 mmHg at 25°C |
| Index of Refraction | 1.679 |
| 4-Quinazolinamine, N-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5H)-yl)-6-methyl- |
| N-[(3-Amino-3-oxetanyl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methyl-4-quinazolinamine |